Amexdrug Corporation (AXRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2017 | 2016 | 2015 |
|---|---|---|---|
| Operating Cash Flow | 27.48 Thousand | -121.2 Thousand | 17.63 Thousand |
| Net Income | 111.36 Thousand | 73.75 Thousand | 100.31 Thousand |
| Depreciation & Amortization | 7420.00 | 7897.00 | 9220.00 |
| Deferred income taxes | 7300.00 | -5100.00 | 16.9 Thousand |
| Stock-based compensation | - | - | - |
| Change in working capital | -92.6 Thousand | -199.92 Thousand | -109.09 Thousand |
| Other non-cash items | -96.14 Thousand | 311.52 Thousand | 99.14 Thousand |
| Investing Cash Flow | - | - | 780.00 |
| Investments in PPE | - | - | -800.00 |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | 1580.00 |
| Other Investing Activities | - | - | - |
| Financing Cash Flow | -10.63 Thousand | 104.07 Thousand | 44.71 Thousand |
| Debt repayment | -8361.00 | -105 Thousand | -45.81 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | -2274.00 | -928.00 | -1095.00 |
| Common Stock Issuance | - | - | - |
| Other Financing Activities | - | - | - |
| Accounts receivables | 407.43 Thousand | -217.03 Thousand | -180 Thousand |
| Accounts payables | -92.75 Thousand | 315.04 Thousand | 268.61 Thousand |
| Inventory | -209.69 Thousand | -391.57 Thousand | -169.02 Thousand |
| Other working capital | -197.59 Thousand | 93.63 Thousand | -28.68 Thousand |
| Cash at beginning of period | 218.57 Thousand | 235.7 Thousand | 172.56 Thousand |
| Cash at end of period | 235.42 Thousand | 218.57 Thousand | 235.7 Thousand |
| Capital Expenditure | - | - | -800.00 |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 16.85 Thousand | -17.12 Thousand | 63.13 Thousand |
| Free Cash Flow | 27.48 Thousand | -121.2 Thousand | 16.83 Thousand |
| Breakdown | 2017 FY | 2016 FY | 2015 FY | 2013 Q2 |
|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - |
| Net Income | 111.36 Thousand | 73.75 Thousand | 100.31 Thousand | 57.88 |
| Depreciation & Amortization | 7420.00 | 7897.00 | 9220.00 | 17.66 |
| Deferred income taxes | 7300.00 | -5100.00 | 16.9 Thousand | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | -92.6 Thousand | -199.92 Thousand | -109.09 Thousand | -128.04 |
| Other non-cash items | -96.14 Thousand | 311.52 Thousand | 99.14 Thousand | 199.10 |
| Investing Cash Flow | - | - | 780.00 | 0.43 |
| Investments in PPE | - | - | -800.00 | - |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | 1580.00 | - |
| Other Investing Activities | - | - | - | 0.43 |
| Financing Cash Flow | -10.63 Thousand | 104.07 Thousand | 44.71 Thousand | -110.43 |
| Debt repayment | -8361.00 | -105 Thousand | -45.81 Thousand | -12.31 |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | -2274.00 | -928.00 | -1095.00 | -0.40 |
| Common Stock Issuance | - | - | - | - |
| Other Financing Activities | - | - | - | -97.73 |
| Accounts receivables | 407.43 Thousand | -217.03 Thousand | -180 Thousand | -80.64 |
| Accounts payables | -92.75 Thousand | 315.04 Thousand | 268.61 Thousand | - |
| Inventory | -209.69 Thousand | -391.57 Thousand | -169.02 Thousand | 34.20 |
| Other working capital | -197.59 Thousand | 93.63 Thousand | -28.68 Thousand | -81.61 |
| Cash at beginning of period | 218.57 Thousand | 235.7 Thousand | 172.56 Thousand | 125.97 |
| Cash at end of period | 235.42 Thousand | 218.57 Thousand | 235.7 Thousand | 162.57 |
| Capital Expenditure | - | - | -800.00 | - |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 16.85 Thousand | -17.12 Thousand | 63.13 Thousand | 36.59 |
| Free Cash Flow | 27.48 Thousand | -121.2 Thousand | 16.83 Thousand | 146.60 |
1429
2355
9763
NTG
1430
PPSI